Summit Therapeutics SMMT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $16.37M+0.6% | $16.26M+46.9% | $11.07M-82.2% | $62.09M-13.5% | ||
| $488.18M+58.8% | $307.49M+168% | $114.82M— | $0— | ||
| $316K-2.8% | $325K— | $0-100% | $300M— | ||
| $6.54M-41.0% | $11.08M+322% | $2.62M+74.3% | $1.5M-79.0% | ||
| $720.3M+70.0% | $423.75M+123% | $189.71M-71.1% | $656.71M+575% | ||
| $1.06M+317% | $254K+24.5% | $204K-77.5% | $906K+30.5% | ||
| $20.62M+189% | $7.14M+21.9% | $5.86M+40.3% | $4.18M+49.6% | ||
| $2M+7.3% | $1.86M-1.5% | $1.89M+5.3% | $1.8M-10.5% | ||
| $7.21M+183% | $2.55M-41.0% | $4.32M+649% | $577K+239% | ||
| $0— | $0— | $0— | —— | ||
| $751.18M+72.5% | $435.56M+115% | $202.95M-69.4% | $664.17M+486% | ||
| $20.29M+338% | $4.64M+73.8% | $2.67M+651% | $355K-91.9% | ||
| $14.93M+24.6% | $11.98M+121% | $5.43M-3.8% | $5.64M+36.8% | ||
| $3.39M-10.0% | $3.77M+34.0% | $2.81M+66.2% | $1.69M+54.9% | ||
| $72.99M+74.9% | $41.73M+105% | $20.41M-47.4% | $38.78M+51.4% | ||
| $17.5M+407% | $3.45M+5.0% | $3.29M+19.1% | $2.76M+63.4% | ||
| $20.89M+189% | $7.22M+18.3% | $6.1M+37.0% | $4.45M+60.1% | ||
| $1.83M+12.4% | $1.63M+4.4% | $1.56M+9.3% | $1.43M-48.5% | ||
| $92.32M+97.2% | $46.81M-62.6% | $125.26M-76.7% | $537.51M+1,686% | ||
| $0— | $0— | $0— | $0— | ||
| 1B+13,457% | 7.4M+5.1% | 7M+233% | 2.1M+115% | ||
| $2.95B+84.4% | $1.6B+49.9% | $1.07B+111% | $504.77M+31.4% | ||
| -$2.29B-88.9% | -$1.21B-22.3% | -$993.26M-163% | -$378.33M-26.3% | ||
| -$2.54M-11.2% | -$2.29M+6.7% | -$2.45M-29.3% | -$1.89M+13.8% | ||
| $658.86M+69.5% | $388.75M+400% | $77.69M-38.7% | $126.65M+52.1% | ||
| $751.18M+72.5% | $435.56M+115% | $202.95M-69.4% | $664.17M+486% | ||
| $7.21M+183% | $2.55M-41.0% | $4.32M+649% | $577K+239% | ||
| $20.62M+189% | $7.14M+21.9% | $5.86M+40.3% | $4.18M+49.6% | ||
| $20.62M+189% | $7.14M+21.9% | $5.86M+40.3% | $4.18M+49.6% | ||
| $7.21M+183% | $2.55M-41.0% | $4.32M+649% | $577K+239% | ||
| $488.18M+58.8% | $307.49M+168% | $114.82M— | $0— | ||
| $20.62M+189% | $7.14M+21.9% | $5.86M+40.3% | $4.18M+49.6% | ||
| $7.21M+183% | $2.55M-41.0% | $4.32M+649% | $577K+239% | ||
| $14.93M+24.6% | $11.98M+121% | $5.43M-3.8% | $5.64M+36.8% | ||
| $32.1M+64.2% | $19.55M+123% | $8.78M-17.6% | $10.66M+48.2% | ||
| $32.1M+64.2% | $19.55M+123% | $8.78M-17.6% | $10.66M+48.2% | ||
| $14.93M+24.6% | $11.98M+121% | $5.43M-3.8% | $5.64M+36.8% | ||
| $2.28M+27.0% | $1.8M+151% | $717K+8.3% | $662K-26.2% | ||
| $20.89M+189% | $7.22M-93.2% | $106.1M-78.7% | $498.99M+17,836% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 775.4M+5.1% | 737.6M+5.1% | 701.7M+232% | 211.1M+115% | ||
| 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | ||
| $7.75M+5.1% | $7.38M+5.1% | $7.02M+233% | $2.11M+115% | ||
| $0— | $0— | $0— | $0— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $172K+72.0% | $100K+178% | $36K— | —— | ||
| $0— | $0— | $0— | —— | ||
| 0-100% | 4.6M-7.7% | 5M— | —— | ||
| $31.5M+80.6% | $17.44M+139% | $7.29M— | —— | ||
| $0— | $0— | $0— | —— | ||
| $172K+72.0% | $100K+178% | $36K— | —— | ||
| $0-100% | $4.63M-7.7% | $5.02M— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $1B0.0% | $1B0.0% | $1B0.0% | $1B+186% | ||
| $775.37M+5.1% | $737.63M+5.1% | $701.66M+232% | $211.09M+115% | ||
| $775.37M+5.1% | $737.63M+5.1% | $701.66M+232% | $211.09M+115% | ||
| $696.91M+76.0% | $395.99M+245% | $114.78M— | —— | ||
| $0— | $0— | $0— | —— | ||
| $697.08M+76.0% | $396.09M+245% | $114.82M— | —— | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | ||
| $4M-52.1% | $8.34M+469% | $1.47M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Summit Therapeutics's total assets?
- Summit Therapeutics (SMMT) holds $647.9M in total assets, up 68.8% year over year.
- How much debt does Summit Therapeutics have?
- Summit Therapeutics carries $20.0M in total debt against $545.9M of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Summit Therapeutics have?
- Summit Therapeutics holds $8.2M in cash and equivalents.
- Can Summit Therapeutics cover its short-term obligations?
- Its current ratio is 7.41 — current assets exceed current liabilities.
- Where does Summit Therapeutics's balance sheet data come from?
- Every line is extracted from Summit Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.